Effect of silver on burn wound infection control and healing: review of the literature.
暂无分享,去创建一个
Bishara S Atiyeh | Michel Costagliola | Shady N Hayek | B. Atiyeh | S. Hayek | M. Costagliola | S. Dibo | Saad A Dibo
[1] A. W. Wilkinson,et al. RESEARCH IN BURNS , 1968 .
[2] A. Bard,et al. Chemical, Electrochemical, Gravimetric, and Microscopic Studies on Antimicrobial Silver Films , 2002 .
[3] C. Lok,et al. [Topical silver sulfadiazine-induced acute renal failure]. , 2005, Annales de dermatologie et de venereologie.
[4] R. Burrell,et al. Infection and the chronic wound: a focus on silver. , 2005, Advances in skin & wound care.
[5] C. Rowland‐Payne. Argyria from excessive use of topical silver sulphadiazine , 1992 .
[6] R. Zapata-Sirvent,et al. Tissue deposition of silver following topical use of silver sulphadiazine in extensive burns. , 1985, Burns, including thermal injury.
[7] L. Salas Campos,et al. [Topical chemotherapy for the treatment of burns]. , 2005, Revista de enfermeria.
[8] D. Smith,et al. Regional and institutional variation in burn care. , 1995, Journal of Burn Care and Rehabilitation.
[9] R. F. Ryan. Topical therapy of burns. , 1972, Postgraduate medicine.
[10] P. Friden,et al. Antimicrobial activity of silver nitrate against periodontal pathogens. , 2001, Journal of periodontal research.
[11] R. Burrell,et al. Efficacy of topical silver against fungal burn wound pathogens. , 1999, American journal of infection control.
[12] Ş. Çavuşlu,et al. Comparison of silver-coated dressing (Acticoat), chlorhexidine acetate 0.5% (Bactigrass), and silver sulfadiazine 1% (Silverdin) for topical antibacterial effect in Pseudomonas aeruginosa-contaminated, full-skin thickness burn wounds in rats. , 2005, The Journal of burn care & rehabilitation.
[13] D. Mitlin,et al. Impact of heat on nanocrystalline silver dressings. Part II: Physical properties. , 2005, Biomaterials.
[14] S. Bohbot,et al. A silver sulphadiazine-impregnated lipidocolloid wound dressing to treat second-degree burns. , 2004, Journal of wound care.
[15] V. Poon,et al. Antimicrobial activities of silver dressings: an in vitro comparison. , 2006, Journal of medical microbiology.
[16] J. Fish,et al. The use of silver coated dressings on donor site wounds: a prospective, controlled matched pair study. , 2001, Burns : journal of the International Society for Burn Injuries.
[17] G. Turnbull. A look at the purpose and outcomes of colostomy irrigation. , 2003, Ostomy/wound management.
[18] R. Kimble,et al. Cytotoxicity of topical antimicrobial agents used in burn wounds in Australasia , 2004, ANZ journal of surgery.
[19] C. Bladin,et al. Argyria from excessive use of topical silver sulphadiazine , 1992, The Lancet.
[20] C. Mkony,et al. A comparison of topical Phenytoin with Silverex in the treatment of superficial dermal burn wounds. , 2002, The Central African journal of medicine.
[21] M. Trop. Silver-coated dressing acticoat caused raised liver enzymes and argyria-like symptoms in burn patient. , 2006, The Journal of trauma.
[22] A. Buret,et al. Early healing events in a porcine model of contaminated wounds: effects of nanocrystalline silver on matrix metalloproteinases, cell apoptosis, and healing , 2002, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[23] Michael Wagener,et al. An in vitro assessment of the antibacterial properties and cytotoxicity of nanoparticulate silver bone cement. , 2004, Biomaterials.
[24] P. Lam,et al. In vitro cytotoxicity testing of a nanocrystalline silver dressing (Acticoat) on cultured keratinocytes. , 2004, British journal of biomedical science.
[25] R. Burrell,et al. Impact of heat on nanocrystalline silver dressings. Part I: Chemical and biological properties. , 2005, Biomaterials.
[26] A. Mason,et al. Topical silver treatment after escharectomy of infected full thickness burn wounds in rats. , 2005, The Journal of trauma.
[27] A. Lansdown,et al. Silver. 2: Toxicity in mammals and how its products aid wound repair. , 2002, Journal of wound care.
[28] W. Eaglstein,et al. Wound healing. The effects of topical antimicrobial agents. , 1979, Archives of dermatology.
[29] K. Bader. Organ Deposition of Silver Following Silver Nitrate Therapy of Burns , 1966, Plastic and reconstructive surgery.
[30] G. Young,et al. Myoclonic status epilepticus following repeated oral ingestion of colloidal silver , 2004, Neurology.
[31] R. Conyers,et al. Determination of silver in blood, urine, and tissues of volunteers and burn patients. , 1991, Clinical chemistry.
[32] E. Capodaglio,et al. Effects of silver in isolated rat hepatocytes. , 1988, Toxicology letters.
[33] H. N. Harrison. Pharmacology of sulfadiazine silver. Its attachment to burned human and rat skin and studies of gastrointestinal absorption and extension. , 1979, Archives of surgery.
[34] J. Lawrence,et al. Mechanism of Prophylaxis by Silver Compounds against Infection of Burns , 1970, British medical journal.
[35] H. Klasen,et al. A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver. , 2000, Burns : journal of the International Society for Burn Injuries.
[36] A. Hendry,et al. Silver-resistant Enterobacteriaceae from hospital patients. , 1979, Canadian journal of microbiology.
[37] C. Rix,et al. Passage of silver ions through membrane-mimetic materials, and its relevance to treatment of burn wounds with silver sulfadiazine cream. , 1997, Clinical chemistry.
[38] R. Burrell,et al. Wound management in an era of increasing bacterial antibiotic resistance: a role for topical silver treatment. , 1998, American journal of infection control.
[39] R. Robinson,et al. Benign Rheumatoid Arthritis of the Aged , 1974, British medical journal.
[40] R. Demling,et al. The rate of re-epithelialization across meshed skin grafts is increased with exposure to silver. , 2002, Burns : journal of the International Society for Burn Injuries.
[41] D. Herndon,et al. In vitro toxicity of topical antimicrobial agents to human fibroblasts. , 1989, The Journal of surgical research.
[42] R. Kirsner,et al. MATRIX METALLOPROTEINASES IN NORMAL AND IMPAIRED WOUND HEALING: A POTENTIAL ROLE OF NANOCRYSTALLINE SILVER , 2001 .
[43] J. Heggers,et al. Acticoat versus Silverlon: The Truth , 2002 .
[44] R. Conyers,et al. Do burn patients have a silver lining? , 1992, Burns : journal of the International Society for Burn Injuries.
[45] H. Westh,et al. Bacterial colonization and healing of venous leg ulcers , 1996, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[46] A. Massè,et al. Silver coated materials for external fixation devices: in vitro biocompatibility and genotoxicity. , 2002, Biomaterials.
[47] Y. Akagawa,et al. Cytotoxicity of antimicrobial tissue conditioners containing silver-zeolite. , 2003, The International journal of prosthodontics.
[48] R. E. Hall,et al. Inhibitory and cidal antimicrobial actions of electrically generated silver ions. , 1987, Journal of oral and maxillofacial surgery.
[49] M. Robson. Wound Infection: A Failure of Wound Healing Caused by an Imbalance of Bacteria , 1997 .
[50] M. Hollinger. Toxicological aspects of topical silver pharmaceuticals. , 1996, Critical reviews in toxicology.
[51] J. Gearhart,et al. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. , 2005, Toxicology in vitro : an international journal published in association with BIBRA.
[52] Y. Kuroyanagi,et al. Evaluation of a synthetic wound dressing capable of releasing silver sulfadiazine. , 1991, The Journal of burn care & rehabilitation.
[53] Dickinson Sj. Topical therapy of burns in children with silver sulfadiazine. , 1973 .
[54] C. McClain,et al. Serum and urinary silver levels in thermal injury patients. , 1987, Surgery.
[55] K. Dunn,et al. The role of Acticoat with nanocrystalline silver in the management of burns. , 2004, Burns : journal of the International Society for Burn Injuries.
[56] H. Stern. Silver sulphadiazine and the healing of partial thickness burns: a prospective clinical trial. , 1989, British journal of plastic surgery.
[57] J. Schlager,et al. In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[58] William J. Chancellor,et al. Soil Physical Properties , 1994 .
[59] J. Hamilton-miller,et al. Comparison of the in-vitro activities of the topical antimicrobials azelaic acid, nitrofurazone, silver sulphadiazine and mupirocin against methicillin-resistant Staphylococcus aureus. , 1992, The Journal of antimicrobial chemotherapy.
[60] Ae-Ri Cho Lee,et al. Reversal of silver sulfadiazine-impaired wound healing by epidermal growth factor. , 2005, Biomaterials.
[61] W. Stanford,et al. Clinical experience with silver sulfadiazine, a new topical agent for control of pseudomonas infections in burns. , 1969, The Journal of trauma.
[62] R. Burrell,et al. An Electrochemical Analysis of Thin Silver Films Produced by Reactive Sputtering , 2001 .
[63] R. Burrell,et al. Comparative evaluation of the antimicrobial activity of ACTICOAT antimicrobial barrier dressing. , 1999, The Journal of burn care & rehabilitation.
[64] A D Russell,et al. Antimicrobial activity and action of silver. , 1994, Progress in medicinal chemistry.
[65] D. Supp,et al. Evaluation of cytotoxicity and antimicrobial activity of Acticoat Burn Dressing for management of microbial contamination in cultured skin substitutes grafted to athymic mice. , 2005, The Journal of burn care & rehabilitation.
[66] A. Griffiths-Jones. Methicillin-resistant Staphylococcus aureus in wound care. , 1995, Journal of wound care.
[67] S. Shah,et al. Silver sulphadiazine: a comprehensive in vitro reassessment. , 1993, Chemotherapy.
[68] Martínez de la Chica Am,et al. Topical chemotherapy for the treatment of burns , 2005 .
[69] A. Lansdown,et al. Silver. I: Its antibacterial properties and mechanism of action. , 2002, Journal of wound care.
[70] F. Vazquez,et al. Resistance to antibiotics and inorganic ions in virulent bacterial strains from a hospital. , 1989, Journal of chemotherapy.
[71] S. Modak,et al. Binding of silver sulfadiazine to the cellular components of Pseudomonas aeruginosa. , 1973, Biochemical pharmacology.
[72] K. Neoh,et al. In vitro antibacterial and cytotoxicity assay of multilayered polyelectrolyte-functionalized stainless steel. , 2006, Journal of biomedical materials research. Part A.
[73] Fu-qiang Zhang,et al. [Comparison of the cytotoxicity in vitro among six types of nano-silver base inorganic antibacterial agents]. , 2005, Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology.
[74] D. Bassett,et al. A study of 245 infected surgical wounds in Singapore. , 1992, The Journal of hospital infection.
[75] H J Klasen,et al. Historical review of the use of silver in the treatment of burns. I. Early uses. , 2000, Burns : journal of the International Society for Burn Injuries.
[76] R. Sheridan,et al. Once-daily wound cleansing and dressing change: efficacy and cost. , 1997, The Journal of burn care & rehabilitation.
[77] C. Lok,et al. Insuffisance rénale aiguë après application topique de sulfadiazine argentique , 2005 .
[78] M. Robson,et al. Wound Infection: A Failure of Wound Healing Caused by an Imbalance of Bacteria , 1997 .
[79] C. Sawhney,et al. Long-term experience with 1 per cent topical silver sulphadiazine cream in the management of burn wounds. , 1989, Burns : journal of the International Society for Burn Injuries.
[80] C. Moyer,et al. Treatment of Large Human Burns With 0.5% Silver Nitrate Solution , 1965 .
[81] H. Nikaido,et al. Silver-resistant mutants of Escherichia coli display active efflux of Ag+ and are deficient in porins , 1997, Journal of bacteriology.
[82] S. Chhibber,et al. Susceptibility of multidrug-resistant isolates ofKlebsiella pneumoniae to silver nitrate , 2008, Folia Microbiologica.
[83] J. Laws. State-of-the-art burn treatment. , 1996, Occupational health & safety.
[84] S. Sano,et al. Absorption, excretion and tissue distribution of silver sulphadiazine. , 1982, Burns, including thermal injury.
[85] H. Liedberg,et al. Assessment of silver-coated urinary catheter toxicity by cell culture , 2004, Urological Research.
[86] A. Gupta,et al. Effects of Halides on Plasmid-Mediated Silver Resistance in Escherichia coli , 1998, Applied and Environmental Microbiology.
[87] R. Burrell. A scientific perspective on the use of topical silver preparations. , 2003, Ostomy/Wound Management.
[88] V. Poon,et al. In vitro cytotoxity of silver: implication for clinical wound care. , 2004, Burns : journal of the International Society for Burn Injuries.
[89] K. Ziegler,et al. Reduced Cellular Toxicity of a New Silver-Containing Antimicrobial Dressing and Clinical Performance in Non-Healing Wounds , 2006, Skin Pharmacology and Physiology.